查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370928

非處方鎮痛藥市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按藥物類型、配銷通路、地區、競爭細分

Over-the-Counter Analgesics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Type, By Distribution Channel, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球非處方 (OTC) 鎮痛藥市場估值達到 190.7 億美元，並預計在預測期內強勁成長，預計年複合成長率 (CAGR) 為 8.00%，預計將達到2028 年將達到301.6億美元。

介紹：

細胞穿透勝肽（CPP）代表一類能夠跨細胞膜運輸連接分子的勝肽。這一特性使它們成為增強治療性蛋白質和勝肽通過細胞膜的滲透性的有前途的方法。近年來，細胞穿透勝肽（CPP）因其在跨細胞膜遞送各種治療劑方面的潛力而受到極大關注。受到塑造該行業格局的關鍵因素的影響，這種濃厚的興趣正在推動全球細胞穿透勝肽市場的大幅成長。

市場概況
預測期 2024-2028
2022 年市場規模 190.7億美元
2028 年市場規模 301.6億美元
2023-2028 年年複合成長率 8%
成長最快的細分市場 網路藥局
最大的市場 北美洲

主要市場促進因素：

1. 人口老化和慢性病的增加：

全球非處方（OTC）鎮痛藥市場受到兩個重要因素的影響：人口老化和慢性病的流行。老年人經常需要緩解疼痛來控制慢性病，導致對非處方鎮痛藥的持續需求。便利性、可近性以及避免使用強效處方藥的願望導致老年人偏好非處方鎮痛藥。慢性病通常會導致持續的疼痛和不適，從而推動對止痛藥物（包括非處方止痛藥）的持續需求。這些藥物提供了便利性和可及性，無需處方，使其成為治療與慢性病相關的日常疼痛的首選。慢性病影響各個年齡層的個人，擴大了針對慢性疼痛的非處方止痛藥市場。隨著人們主動控制疼痛，對慢性病的認知和教育的提高推動了對非處方止痛藥的需求。例如，美國在 2021/22 學年報告了 4,998 起受傷事件，因此需要針對運動相關損傷提供有效的止痛方案。

2. 消費者意識和自我保健趨勢不斷增強：

消費者意識的提高和自我照護趨勢對全球非處方 (OTC) 鎮痛藥市場產生了重大影響。這些趨勢反映了消費者偏好和行為的變化，影響個人緩解疼痛和整體健康的方式。知情的消費者在網路和其他來源現成的健康資訊的鼓勵下尋求了解疼痛管理方案。自我保健趨勢提倡個人對健康和福祉的責任，引導個人獨立處理疼痛等輕微健康問題。非處方鎮痛藥為消費者提供了一種方便易用的方法來緩解疼痛，無需醫生處方。這些藥物在藥局、超市、便利商店和線上平台上隨處可見。現代生活方式的特徵是日程繁忙和壓力增加，偶爾會導致疼痛和不適。非處方鎮痛藥提供快速有效的解決方案，使個人能夠保持生產力和生活品質。隨著消費者意識的增強，製造商可以進行有針對性的行銷活動，向消費者宣傳其非處方鎮痛產品的好處和正確使用方法。研發的投資可以帶來滿足特定疼痛緩解需求的創新產品。

3. 醫療費用上漲：

醫療保健成本的增加極大地影響了全球非處方（OTC）鎮痛藥市場。不斷上升的醫療保健費用促使個人和醫療保健系統尋求具有成本效益的解決方案來管理輕微的健康問題，包括緩解疼痛。非處方鎮痛藥為緩解輕度至中度疼痛提供了處方藥的經濟替代品。隨著醫療保健成本的上升，消費者可能更喜歡非處方藥，以避免與醫生就診、處方和自付費用相關的額外費用。當不需要立即就醫時，不斷上漲的醫療費用可能會促使人們轉向非處方止痛藥來緩解疼痛。這些藥物提供了一種經濟有效的方法來解決疼痛，可能節省資源並防止輕微疼痛升級為更嚴重的健康問題。非處方止痛藥可能是首選，尤其是當保險計劃的免賠額較高或非處方藥承保範圍有限時。

4、產品創新與行銷：

產品創新和行銷策略在推動全球非處方 (OTC) 鎮痛藥市場的成長中發揮關鍵作用。這些因素影響消費者的看法、偏好和購買決策，最終影響市場擴張。創新的配方和給藥方法提高了 OTC 鎮痛藥緩解疼痛的有效性、速度或便利性。例如，速溶片劑、貼片、凝膠劑和噴霧劑，可滿足不同消費者的喜好和需求。針對偏頭痛或關節炎等特定類型的疼痛客製化非處方止痛藥，吸引了尋求符合其獨特疼痛管理需求的解決方案的消費者。將具有鎮痛特性的植物成分融入非處方藥產品中，滿足了尋求天然或草藥替代品的注重健康的消費者的偏好。非處方止痛藥的緩釋功能可提供更持久的疼痛緩解，減少頻繁給藥的需要。

主要市場挑戰：

1. 監理審查與安全問題：

監管審查和安全問題可能會阻礙全球非處方 (OTC) 鎮痛藥市場的成長。監管機構對非處方藥執行嚴格的安全標準，以確保消費者的福祉。製造商必須遵守有關活性成分、劑量和潛在藥物交互作用的指南。如果某些成分或配方被認為不安全，監管機構可以限制產品或將其從市場上撤下。不良事件、意外副作用或產品召回可能會削弱消費者對非處方鎮痛產品的信任，導致銷售下降和監管審查加強，從而阻礙市場成長。針對特定族群（例如兒童或孕婦）的年齡限制或警告可能會限制目標受眾並縮小整體市場規模。全面的警告標籤也可能影響產品的使用，引起消費者的擔憂。

2. 專利到期和學名藥競爭：

專利到期和學名藥競爭可能會阻礙全球非處方 (OTC) 鎮痛藥市場的成長。專利到期使學名藥製造商能夠生產和銷售該藥物的同等版本，從而導致競爭加劇。學名藥的價格通常低於品牌藥，隨著消費者轉向更實惠的選擇，市場價值可能會降低。在功效和安全性方面對學名藥等效性的認知可能會影響品牌非處方鎮痛藥的市場佔有率，特別是當消費者選擇較便宜的學名藥時。

主要市場趨勢：

1. 個人化止痛解決方案：

個人化止痛解決方案有可能對全球非處方 (OTC) 鎮痛藥市場的成長產生重大影響。個人化涉及根據個人需求和偏好客製化產品，與不斷變化的醫療保健和消費者趨勢保持一致。客製化解決方案使非處方鎮痛藥物能夠解決特定的疼痛類型，例如偏頭痛、經痛或關節不適，滿足不同的消費者需求並可能增加對專業產品的需求。個人化透過提供針對消費者獨特需求而設計的產品、鼓勵產品選擇和品牌忠誠度來促進消費者參與。

2. 監管轉變與成分審查：

監管轉變和對非處方鎮痛成分審查的加強影響著全球非處方 (OTC) 鎮痛藥市場。法規和成分評估的變化會影響產品配方、標籤和消費者認知。嚴格的監管要求可能會成為新進入者的進入壁壘，可能會延遲創新產品的推出並阻礙市場成長。國際監管變化可以標準化成分清單、安全標準和標籤要求，從而可能限制區域產品的差異。監管轉變可能需要額外的測試和記錄來證明產品的安全性和有效性，從而增加成本並推遲產品發布。成分審查可能會影響供應商關係，如果使用受限成分，則需要替代來源，從而影響供應鏈和產品一致性。

細分洞見：

藥物類型見解：

在藥物類型領域，非類固醇抗發炎藥（NSAID）預計將大幅市場成長。非類固醇抗發炎藥在治療各種病症方面的多功能性、緩解疼痛的有效性以及抗發炎特性，使得非類固醇抗發炎藥物對尋求非處方藥止痛選擇的消費者俱有吸引力。針對特定疼痛類型（例如經痛或背痛）的有針對性的行銷可以吸引尋求量身定做的疼痛緩解解決方案的消費者。

最終用途見解：

零售藥局部門一直在市場上佔據主導地位，為消費者購買非處方止痛藥提供了便利性和可近性。零售藥房連鎖店的廣泛存在確保了快速獲得止痛產品，知識淵博的藥劑師提供指導和建議。零售藥局的線上平台擴大了可近性，進一步促進了市場成長。

區域見解：

北美，特別是美國，在 2022 年成為非處方 (OTC) 鎮痛藥市場的領導者。人口眾多、購買力強、慢性疼痛患病率高以及消費者的健康和保健意識有助於從而奠定了北美市場的主導地位。非處方鎮痛藥的自我保健趨勢和便利性符合北美消費者的生活方式和偏好，進一步推動市場成長。發達的零售藥房網路和電子商務基礎設施提高了該地區非處方止痛藥的可及性。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球非處方 (OTC) 鎮痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 依藥物類型
    • 按配銷通路
    • 按地區

第 6 章：北美非處方 (OTC) 鎮痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲非處方 (OTC) 止痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區非處方 (OTC) 止痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲非處方 (OTC) 止痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲非處方 (OTC) 鎮痛藥市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依藥物類型（對乙醯氨基酚、非類固​​醇類抗發炎藥 (NSAID)、水楊酸鹽和其他鎮痛藥）
    • 按配銷通路（醫院藥房、零售藥房、網路藥房）
    • 按國家/地區
  • MEA：國家分析
    • 南非非處方 (OTC) 止痛藥
    • 沙烏地阿拉伯非處方 (OTC) 止痛藥
    • 阿拉伯聯合大公國非處方 (OTC) 鎮痛藥

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球非處方 (OTC) 止痛藥市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Bayer AG.
    • Boehringer Ingelheim International GmbH
    • Johnson & Johnson Services Inc
    • GSK plc
    • Pfizer Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • AstraZeneca
    • Merck & Co Inc.

第 16 章：策略建議

簡介目錄
Product Code: 17073

The Global Over-the-Counter (OTC) Analgesics Market reached a valuation of USD 19.07 Billion in 2022 and is poised for robust growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.00% and is expected to reach USD 30.16 Billion through 2028.

Introduction:

Cell-penetrating peptides (CPPs) represent a class of peptides capable of transporting linked molecules across cellular membranes. This property makes them a promising approach for enhancing the permeability of therapeutic proteins and peptides through cellular membranes. Recent years have witnessed significant attention directed towards cell-penetrating peptides (CPPs) due to their potential in delivering various therapeutic agents across cellular membranes. This heightened interest is driving substantial growth in the global cell-penetrating peptides market, influenced by key factors shaping this industry's landscape.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 19.07 Billion
Market Size 2028USD 30.16 Billion
CAGR 2023-20288%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Key Market Drivers:

1. Rising Aging Population and Chronic Conditions:

The global over-the-counter (OTC) analgesics market is influenced by two significant factors: the aging population and the prevalence of chronic conditions. Older individuals frequently require pain relief to manage chronic conditions, leading to sustained demand for OTC analgesics. Convenience, accessibility, and a desire to avoid potent prescription medications contribute to the preference for OTC analgesics among older individuals. Chronic conditions often result in ongoing pain and discomfort, driving consistent demand for pain relief medications, including OTC analgesics. These medications offer convenience and accessibility without the need for a prescription, making them a favored choice for managing daily pain associated with chronic conditions. Chronic conditions affect individuals across various age groups, expanding the market for OTC analgesics targeting chronic pain. Heightened awareness and education about chronic conditions drive demand for OTC analgesics as individuals proactively manage their pain. The United States, for instance, reported 4,998 injuries during the academic year 2021/22, creating a need for effective pain relief options among sports-related injuries.

2. Growing Consumer Awareness and Self-Care Trends:

Increasing consumer awareness and self-care trends significantly impact the global Over-the-Counter (OTC) analgesics market. These trends reflect changing consumer preferences and behaviors, influencing how individuals approach pain relief and overall well-being. Informed consumers seek to understand pain management options, encouraged by readily available health information through the internet and other sources. Self-care trends promote personal responsibility for health and well-being, leading individuals to manage minor health issues, such as pain, independently. OTC analgesics offer a convenient and accessible means for consumers to address pain without the need for a doctor's prescription. These medications are widely available in pharmacies, supermarkets, convenience stores, and online platforms. Modern lifestyles, characterized by busy schedules and increased stress, contribute to occasional pain and discomfort. OTC analgesics offer quick and effective solutions, enabling individuals to maintain productivity and quality of life. As consumer awareness grows, manufacturers can engage in targeted marketing campaigns to educate consumers about their OTC analgesic products' benefits and appropriate usage. Investments in research and development can lead to innovative products catering to specific pain relief needs.

3. Rising Healthcare Costs:

Increasing healthcare costs significantly influence the global Over-the-Counter (OTC) analgesics market. Escalating healthcare expenses drive individuals and healthcare systems to seek cost-effective solutions for managing minor health issues, including pain relief. OTC analgesics offer affordable alternatives to prescription medications for addressing mild to moderate pain. As healthcare costs rise, consumers may prefer OTC options, avoiding additional expenses associated with doctor visits, prescriptions, and co-pays. Rising healthcare costs may prompt individuals to turn to OTC analgesics for pain relief when immediate medical attention is unnecessary. These medications provide a cost-effective means to address pain, potentially conserving resources and preventing the escalation of minor pain into more serious health issues. OTC analgesics may be preferred, especially when insurance plans have high deductibles or limited coverage for non-prescription medications.

4. Product Innovation and Marketing:

Product innovation and marketing strategies play pivotal roles in driving the growth of the global Over-the-Counter (OTC) analgesics market. These factors influence consumer perceptions, preferences, and purchasing decisions, ultimately shaping market expansion. Innovative formulations and delivery methods enhance the effectiveness, speed, or convenience of pain relief offered by OTC analgesics. Examples include fast-dissolving tablets, patches, gels, and sprays, catering to diverse consumer preferences and needs. Tailoring OTC analgesics for specific types of pain, such as migraines or arthritis, attracts consumers seeking solutions aligned with their unique pain management requirements. Incorporating botanical ingredients with analgesic properties into OTC products addresses the preferences of health-conscious consumers seeking natural or herbal alternatives. Extended-release capabilities in OTC analgesics provide longer-lasting pain relief, reducing the need for frequent dosing.

Key Market Challenges:

1. Regulatory Scrutiny and Safety Concerns:

Regulatory scrutiny and safety concerns can impede the growth of the global Over-the-Counter (OTC) analgesics market. Regulatory agencies enforce stringent safety standards for OTC medications to ensure consumer well-being. Manufacturers must adhere to guidelines regarding active ingredients, dosages, and potential medication interactions. Regulatory authorities can restrict or remove products from the market if certain ingredients or formulations are deemed unsafe. Adverse events, unexpected side effects, or product recalls can erode consumer trust in OTC analgesic products, leading to decreased sales and heightened regulatory scrutiny, hindering market growth. Age restrictions or warnings for specific populations, such as children or pregnant women, can limit the target audience and reduce the overall market size. Comprehensive warning labels may also impact product use, raising consumer concerns.

2. Patent Expirations and Generic Competition:

Patent expirations and generic competition can hinder the growth of the global Over-the-Counter (OTC) analgesics market. Patent expiration enables generic manufacturers to produce and market equivalent versions of the drug, leading to increased competition. Generic drugs are typically priced lower than their brand-name counterparts, potentially reducing the market value as consumers switch to more affordable options. The perception of generic equivalence in terms of efficacy and safety can impact the market share of brand-name OTC analgesics, particularly when consumers opt for less expensive generic versions.

Key Market Trends:

1. Personalized Pain Relief Solutions:

Personalized pain relief solutions have the potential to significantly influence the growth of the global Over-the-Counter (OTC) analgesics market. Personalization involves tailoring products to individual needs and preferences, aligning with evolving healthcare and consumer trends. Customized solutions enable OTC analgesics to address specific pain types, such as migraines, menstrual pain, or joint discomfort, meeting diverse consumer needs and potentially increasing demand for specialized products. Personalization fosters consumer engagement by offering products designed for their unique requirements, encouraging product selection and brand loyalty.

2. Regulatory Shifts and Ingredient Scrutiny:

Regulatory shifts and increased scrutiny of OTC analgesic ingredients impact the global Over-the-Counter (OTC) analgesics market. Changes in regulations and ingredient assessments influence product formulation, labeling, and consumer perception. Stringent regulatory requirements may serve as barriers to entry for new entrants, potentially delaying the introduction of innovative products and hindering market growth. International regulatory shifts can standardize ingredient lists, safety standards, and labeling requirements, potentially limiting regional product variations. Regulatory shifts may necessitate additional testing and documentation to prove product safety and efficacy, increasing costs and delaying product launches. Ingredient scrutiny can affect supplier relationships, requiring alternative sources if restricted ingredients are used, impacting supply chains and product consistency.

Segmental Insights:

Drug Type Insights:

Within the drug type segment, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are expected to witness substantial market growth. Versatility in addressing various conditions, effectiveness in providing pain relief, and anti-inflammatory properties contribute to the appeal of NSAIDs among consumers seeking OTC pain relief options. Targeted marketing for specific pain types, such as menstrual pain or back pain, can attract consumers seeking tailored pain relief solutions.

End Use Insights:

The Retail Pharmacies segment has been dominant in the market, offering convenience and accessibility for consumers to purchase OTC analgesics. The widespread presence of retail pharmacy chains ensures quick access to pain relief products, with knowledgeable pharmacists providing guidance and recommendations. Online platforms of retail pharmacies expand accessibility, further contributing to market growth.

Regional Insights:

North America, particularly the United States, has been the leader in the Over-the-Counter (OTC) Analgesics Market in 2022. A large population, strong purchasing power, high prevalence of chronic pain conditions, and consumer awareness of health and wellness contribute to the dominance of North America in the market. The self-care trend and the convenience of OTC analgesics align with the lifestyle and preferences of North American consumers, further driving market growth. Well-developed retail pharmacy networks and e-commerce infrastructure enhance the accessibility of OTC analgesics in the region.

Key Market Players

  • Bayer AG.
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Merck & Co Inc.

Report Scope:

In this report, the Global Over-the-Counter (OTC) Analgesics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over-the-Counter (OTC) Analgesics Market, By Drug Type:

  • Acetaminophen
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Other Analgesics

Over-the-Counter (OTC) Analgesics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Over-the-Counter (OTC) Analgesics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Over-the-Counter (OTC) Analgesics Market.

Available Customizations:

  • Global Over-the-Counter (OTC) Analgesics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Over-the-Counter (OTC) Analgesics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Drug Type
    • 5.3.2 By Distribution Channel
    • 5.3.3 By Region

6. North America Over-the-Counter (OTC) Analgesics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe Over-the-Counter (OTC) Analgesics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 7.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 8.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Distribution Channel

9. South America Over-the-Counter (OTC) Analgesics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 9.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 10.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Over-the-Counter (OTC) Analgesics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Bayer AG.
    • 15.6.2 Boehringer Ingelheim International GmbH
    • 15.6.3 Johnson & Johnson Services Inc
    • 15.6.4 GSK plc
    • 15.6.5 Pfizer Inc.
    • 15.6.6 Sanofi
    • 15.6.7 Sun Pharmaceutical Industries Ltd.
    • 15.6.8 Takeda Pharmaceutical Company Limited
    • 15.6.9 AstraZeneca
    • 15.6.10 Merck & Co Inc.

16. Strategic Recommendations